A phase 2 study of three low-dose intensity subcutaneous bortezomib regimens in elderly frail patients with untreated multiple myelomaAlessandra Larocca, Antonio Palumbo, Antonietta Falcone et al.|Leukemia|2016Cited by 46
Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapiesS Caltagirone, Paola Omedè, Marina Ruggeri et al.|Haematologica|2014Cited by 22